376 makale bulundu

Association of OBPIIa genetic variants with prodromal Parkinsonian phenotypes and dopaminergic biomarkers in the PPMI cohort.

Jiang C, Kong Z, Zhou Y, He Q, Dou K, Hou B, Li Y, Xie A.

J Neurol Sci · 2026-03-02

DOI: 10.1016/j.jns.2026.125845PMID: 41791219

Correction to: Longitudinal neuromelanin changes in prodromal and early Parkinson's disease in humans and rat model.

Yazar bilgisi kaynakta kontrol edilmeli

Brain Commun · 2026-02-12

DOI: 10.1093/braincomms/fcag030PMID: 41695755

The impact of diabetes mellitus in prodromal Parkinson's disease.

Li G, Li G.

Neurol Sci · 2026-02-05

DOI: 10.1007/s10072-026-08838-3PMID: 41639475

Early Autonomic Burden in Prodromal Parkinson's Disease Predicts Cognitive Impairment.

Prodromal Parkinson Hastalığında Erken Otonom Yük Bilişsel Bozulmayı Tahmin Ediyor.

Martinez-Nunez AE, Mills KA, Seemiller J, Morrow CB, Pontone GM, Mahajan A.

Mov Disord · 2026-01-14

DOI: 10.1002/mds.70202PMID: 41532259

Clinical characteristics and risk factors of depression in prodromal Parkinson's disease.

Xu J, Wang Y, Li Y, Wang H, Liu W.

Front Neurosci · 2026-01-12

DOI: 10.3389/fnins.2025.1708805PMID: 41601546

Compartment-specific correlation of pathological α-synuclein in prodromal Parkinson's disease.

Röttgen S, Sommerauer M, Yan S, Hungerland C, Fink GR, Ophey A, Barbe MT, Müller L, Tamgüney G, Tofaris GK.

Parkinsonism Relat Disord · 2026-01-05

DOI: 10.1016/j.parkreldis.2026.108178PMID: 41512492

Cholinergic degeneration in prodromal and early Parkinson's disease: a link to present and future disease states.

Prodromal ve erken Parkinson hastalığında kolinerjik dejenerasyon: mevcut ve gelecekteki hastalık durumlarına bir bağlantı.

Eisenstein T, Groenewald K, van Hillegondsberg L, Al Hajraf F, Zerenner T, Lawton MA, Ben-Shlomo Y, Griffanti L, Hu MT, Klein JC.

Brain · 2026-01-01

DOI: 10.1093/brain/awaf168PMID: 40326282

Lower serum uric acid levels as a risk factor for depression in prodromal Parkinson's disease: a cohort study.

Liang K, Ouyang Y, Li B, Li T, Tan J, Shuai C, Tang X, Chen Z, Huang Z, Tang X, Jin J, Liang Q, Li Z, Bai QR, Wang X.

Open Life Sci · 2026-01-01

DOI: 10.1515/biol-2025-1309PMID: 42046555

Prodromal Peripheral Immune Cell Profile in Drug-Induced Parkinsonism Relative to Parkinson's Disease.

Lien B, Kasibhatla V, Mawad M, Anekwe J, Friedman JH, Alhusaini S.

Mov Disord Clin Pract · 2025-12-18

DOI: 10.1002/mdc3.70476PMID: 41410235

Ophthalmic symptoms as biomarkers for prodromal and early Parkinson's disease: a scoping review.

Prodromal ve erken Parkinson hastalığı için biyobelirteç olarak oftalmik semptomlar: bir tarama incelemesi.

Łach-Wojnarowicz O, Szejko N, Carvalho V, Siuda A, Dobrowolski D, Wylęgała E, Śmiłowska K.

Neurol Neurochir Pol · 2025-12-09

DOI: 10.5603/pjnns.108151PMID: 41363105

Longitudinal insights from iron accumulation in motor system of prodromal and clinical Parkinson's disease.

Huang S, Zhou L, Li Z, Zeng T, Yang Y, Wang N, Yin Q, Wang X, Wei H, Liu J.

NPJ Parkinsons Dis · 2025-12-06

DOI: 10.1038/s41531-025-01223-5PMID: 41353455

Longitudinal assessment of DNA repair signature trajectory in prodromal versus established Parkinson's disease.

Prodromalde DNA onarım imza yörüngesinin uzunlamasına değerlendirilmesi, yerleşik Parkinson hastalığına karşı.

Anwer D, Montaldo NP, Novoa-Del-Toro EM, Domanska D, Nilsen HL, Polster A.

NPJ Parkinsons Dis · 2025-12-05

DOI: 10.1038/s41531-025-01194-7PMID: 41350539